Braves break silence on Jurickson Profar’s massive PED suspension

The Atlanta Braves issued a statement Tuesday after outfielder Jurickson Profar was suspended 162 games —effectively, the entire 2026 season — for performance enhancing drug use.

MORE: Former Braves star slams Jurickson Profar immediately after PED suspension

Profar, 33, tested positive for exogenous testosterone, which is banned by the joint drug agreement between Major League Baseball and the MLB Players Association.

“We were incredibly disappointed to learn that Jurickson tested positive for a performance-enhancing substance and is in violation of MLB’s Drug Prevention and Treatment Program,” the statement read. “Our players are consistently educated about the Program and the consequences if they are found to be in violation. The Atlanta Braves fully support the Program.”

Profar also will be ineligible for the upcoming World Baseball Classic, where he was set to represent the Netherlands.

The 162-game suspension was triggered because Profar was suspended in March 2025 for testing positive for Chorionic Gonadotropin (hCG). As a first-time offender a year ago, he was suspended 80 games.

Now, Profar faces the prospect of missing the 2026 season altogether. The Players Association has reportedly been asked to appeal his suspension.

The Braves signed Profar to a three-year, $42 million contract in January 2025. After playing 80 games last year and hitting .245, he faces a long road back to delivering any return on the Braves’ investment.